Abstract
TI-201 has been used mainly as a myocardial perfusion agent. Its use as a tumor agent was first described in 1976, and many types of malignancies have been detected with TI-201. However, scintigraphic detection of esophageal cancer by TI-201 has rarely been reported.
| Original language | English |
|---|---|
| Pages (from-to) | 77 |
| Number of pages | 1 |
| Journal | Clinical Nuclear Medicine |
| Volume | 28 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2003 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Esophageal Cancer
- TI-201 Chest SPECT
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'Esophageal Cancer Detected by TI-201 Chest SPECT'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS